info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +1-315-636-4233    uk UK: +44-162-237-0614     in IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
 
Home » Healthcare » Sterility Testing Market Size, Industry Trends & Growth 2030

Sterility Testing Market By Product (Kits and Reagents, Instruments, Services), By Test (Membrane Filtration, Direct Inoculation, Other Sterility Tests), By Application (Pharmaceutical and Biological Manufacturing, Medical Devices Manufacturing, Others Applications), By Geography, Size Share, Global Industry Analysis Report, Forecast, 2021-2030

Published On: May-2022   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2017 - 2020   |   Formats: PDF   |   Report ID: 00865575

Industry Report and Statistics (Facts & Figures) - Number of Tests Conducted & Demand by Product, Test Type & Application

The global sterility testing market will witness a robust CAGR of 12.6%, valued at $161.18 million in 2021, expected to appreciate and reach $469.0 million by 2030, confirms Strategic Market Research. Sterility testing is carried out by pharmaceutical, biotechnological, and medical device firms to examine the raw material quality, process control, and end-product validation. The presence or absence of live bacteria capable of reproducing and replicating under favorable conditions is determined through sterility testing. Moreover, bulk and finished medicinal products, cell banks, and raw materials are subjected to undergo sterility testing. According to the Indian Economic Survey 2021, the domestic market is predicted to rise thrice in the next decade. In 2021, India's domestic pharmaceutical market was valued at US$ 42 billion, and it is expected to grow to US$ 65 billion by 2024 and then to US$ 120-130 billion by 2030.

The sterility testing market is poised to grow in the near future due to increased demand for sterilized items. Also, the growth media must be correctly prepared and tested to ensure that the microbial growth is as efficient as possible during sterility testing. Over the projected period, the increasing innovations in sterility testing technologies are expected to help the development of the industry. According to Mckinsey and Company, between 2014 and 2018, more than 580 healthcare technological agreements worth more than $10 million were completed in the United States, adding up to more than about $83 billion.

 

sterility testing market by share 2020-2030

 

Market Drivers - Increase in Research and Development in the Field of Life Sciences

  • The expanding research and development in life sciences, combined with significant public and private financing, is a primary driver that is fuelling the expansion of the sterility testing industry.

 

  • According to Chemical and Engineering News, the Indian Ministry of Science and Technology allocated a budget of INR 35 billion for the Department of Biotechnology (DBT) of India in the Union Budget for the year 2021-2022, a 25% increase from the previous year. It is primarily for biotechnology research and development, as well as industrial and entrepreneurship development in the country, which will boost the market growth significantly.

 

  • Major industry players are working on business tactics such as mergers, acquisitions, collaborations, and developing new goods to stay ahead of the competition. Furthermore, new firms are engaging in the kit testing market since it provides a steady stream of revenue from the clients.

 

  • Furthermore, due to the yield of more positive sterility testing results as compared to the negative ones, the rise in the demand for pharmaceutical sterility testing market and the need for various types of sterility testing like b/f testing sterility, sterility testing medical devices, sgs sterility testing, hypothesis testing, Vaporized Hydrogen Peroxide (VHP) Ingress Testing, etc. is propelling the overall industry growth.

 

Restraints - Stringent Government Regulations

  • A rise in the sterility testing unit price and the scarcity of qualified sterility test professionals due to strict government rules are highly obstructing the market growth.

 

  • High levels of consolidation, as well as rigid regulatory frameworks and lengthy licensing processes, are significant barriers to new market entrants.

 

Trends and Opportunities - Emerging Markets and Increasing Pharmaceutical Outsourcing

  • Industry players in the pharmaceutical and biopharmaceutical industries are ensuring that environmental monitoring (EM) program is implemented to avoid sterility test failures in the future. The sterilization of the product assures safety and detects early concerns quickly. This aids the firms in maximizing their market position in the service industry. According to India Brand Equity Foundation, Biopharmaceuticals, Bio Services, Bio-agriculture, Bioindustry, and Bioinformatics makeup India's biotechnology industry. In 2020, the Indian biotechnology industry was valued at $70.2 billion; by 2025, it is predicted to be worth $150 billion.

 

  • Further, the governmental bodies are spending a hefty amount of money on the improvisation of the testing procedure. Apart from that, they have also introduced some of the notable FDA guidelines for sterility testing, which is expected to cater to ample growth opportunities for the market in due course of time. According to India Brand Equity Foundation, in FY20, India's medical device market was valued at US$ 10.36 billion. From 2020 to 2025, the industry is predicted to grow at a CAGR of 37%, reaching US$ 50 billion.

 

  • Moreover, scientists from all across the globe are toiling hard in their field of research. They have successfully developed some of the critical sterility testing methods in microbiology, which is expected to extensively fuel market growth.

 

sterility testing market by product 2020-2030

 

Market Analysis Of Different Segments Covered in the Report

Based on Product

  • Kits and Reagents

  • Instruments

  • Services

 

Based on Test

  • Membrane Filtration

  • Direct Inoculation

  • Other Sterility Tests

 

Based on Application

  • Pharmaceutical and Biological Manufacturing

  • Medical devises Manufacturing

  • Others Applications

 

Regional Coverage Analysis

North America

  • U.S.
  • Canada

 

Europe

  • Germany

  • France

  • U.K.

  • Italy

  • Spain

  • Rest of Europe (RoE)

 

Asia

  • China

  • Japan

  • India

  • Rest of Asia (RoA)

 

Product Analysis & Insights

Kits and Reagent segment dominated the market in 2020, and it is predicted to grow significantly. This rise is due to the availability of a wide range of products that help in minimizing the risk of false-negative and false-positive results. Sterility testing pumps are also available, which are designed to fit seamlessly into all the testing facilities that aid in maximizing safety & streamlining workflow. Over the forecasted period, the rising demand for similar items is expected to enhance this segmental growth.

 

Type Analysis & Insights

Membrane filtration dominated the market, owing to technological advancements in membrane filtration design and operations, which increases the filtration efficiency and allows the filtration processes to operate at low temperatures with less energy consumption. According to Bit Rebels, Over the next few years, 47% of businesses is anticipated to increase their usage of connected health solutions. Personal sensor technologies such as wearable gadgets are expected to have a favorable impact on health, according to 71% of physicians.

 

Application Analysis & Insights

The Pharmaceutical and Biological Manufacturing segment is expected to grow and hold a significant proportion of the sterility testing market, which is primarily due to the increased regulatory intervention. According to the India Brand Equity Foundation, with a CAGR of 16.4 percent, the Indian biotechnology industry is predicted to grow from US$ 63 billion in 2019 to US$ 150 billion by 2025. The Indian biotechnology industry will contribute 19 percent of the global biotechnology market by 2025.

 

Region Analysis & Insights

North America had the largest market of sterility testing. The primary reason behind possessing the largest industry share is due to the rise in the research and innovation in the biotechnology and pharmaceutical industries, increased investment in life sciences, rise in the research & development activities of medical technology, and favorable government initiatives in the entire region. According to the Government of Canada's Industrial Research and Development, in-house R&D expenditure by Canadian businesses reached a new landmark of USD 21.7 billion in 2019. By data from seed scientific, the global biotechnology market value is anticipated to reach $727.1 billion by 2025. Moreover, the experts believe that the employment rate in biotech will grow by 5% between the years 2019 and 2029. On the contrary, the Asia-Pacific region is the fastest growing market for sterility testing throughout the forecasted period, which is primarily due to the rise in the expenditure on life science research & the rising trend of pharmaceutical outsourcing to Asian countries like China and India. According to the India Brand Equity Foundation, the Indian pharmaceutical industry supplies more than half of the global demand for vaccines, including 40% of the generic demand in the United States and 25% of all medicine in the United Kingdom. India is the world's third-largest producer of drugs by volume and the fourteenth-largest producer by value. A network of 3,000 medicinal businesses and 10,500 manufacturing units make up the domestic pharmaceutical sector.

 

Sterility Testing Market Report Coverage

Report Attribute

Details

Forecast Period

2020-2027

The market size value in 2021

USD 161.18 Million

Revenue Forecast in 2030

USD 469.0 million

Growth Rate

CAGR of Approximately 12.6%

The base year for estimation

2021

Historical Data

2017 - 2020

Unit

USD Million, CAGR (2021-2030)

Segmentation

By Product, By Test, By Application, By Region

By Product

Kits and Reagents, Instruments, and Services

By Test

Membrane Filtration, Direct Inoculation, and Other Sterility Tests

By Application

Pharmaceutical and biological manufacturing, Medical Devices Manufacturing, and Other Applications.

By Region

North America, Europe, and Asia

Country Space

US, Canada, Germany, France, UK, Japan, China, India, etc.

Company Usability Profiles

BioMérieux, Charles River Laboratories, Inc., Merck KGaA, Sartorius AG, SGS S.A., Sotera Health LLC, and Thermo Fisher Scientific

 

Global Sterility Testing Market Competitive Landscape Analysis

The competitive landscape analysis provides information about the crucial competitors prevailing in the global environment. The comparison is performed based on overall revenue generation, market initiatives, company overview, investment in R&D, company financials, company strengths and weaknesses, global presence, production capacity, production sites and facilities, market potential, etc.

 

  • Merck KGaA

  • Baxter Healthcare Corporation

  • Boston Analytical

  • Neopharm Labs Inc.

  • LexaMed LTD

  • Danaher Corporation

  • Sartorius AG

  • Gibraltar Laboratories

  • Pace Analytical Services, Inc.

  • Sigma-Aldrich Co. LLC.

  • Nelson Laboratories

  • Pacific Biolabs

  • BioConvergence LLC

  • Thermo Fisher Scientific Inc.

  • Toxikon Corporation.

  • Wuxi Apptec

  • Rapid Micro Biosystems, Inc.

 

sterility testing market by region 2020-2030

 

Recent Developments

  • On July 2022, the West Virginia news revealed that U.S scientists had developed a unique and rapid sterility testing (RMT) method known as the USP<71>Sterility-test. It has been regarded as the “gold standard” for sterility tests. Along with the EU Pharmacopeia (EP-2.6.1-Sterility) & Japanese Pharmacopeia (JP-4.06-Sterility Test), they together represent (90+) % of harmonized test processes which is utilized for the identification of sterility for a particular product.

 

  • Charles River Laboratories International, Inc. announced on May, 2021, that it had signed a definitive agreement to acquire Vigene Biosciences, Inc., a leading gene therapy contract development and manufacturing organization (CDMO) in the United States that specializes in viral vector-based gene delivery solutions.

 

  • Thermo Fisher Scientific announced plans to build two additional sterile filling lines in Singapore in October 2020, allowing the company to expand its capacity in the APAC region for vaccine and therapy manufacturing and development.

 

  • Charles River Laboratories International, Inc. and Valence Discovery established a strategic agreement on April, 2021, to give clients access to Valence's artificial intelligence platform for molecular property prediction, generative chemistry, and multiparameter optimization.

 

  • In September 2021, Nelson Labs and Sterigenics Germany GmbH inaugurated a new center of excellence in Wiesbaden, with expanded sterilization capabilities and microbiological laboratory testing. The expansion will assist in terms of addressing the increased demand for these services among pharmaceutical and medical device businesses.

 

  • Charles River Laboratories International, Inc. announced the acquisition of Retrogenix Limited, an early-stage contract research organization (CRO) that offers specialized bioanalytical services using its unique cell microarray technology, on March 2021.

 

Various Devices that the Market Leaders are Manufacturing

Name of the product

Function

Key Players

Filter Paper

 

Filter papers are often used in quantitative and qualitative analysis.

Sigma-Aldrich Co. LLC.

 

QuantStudio Real-Time PCR systems

Changes in gene expression as little as 1.5-fold can be detected with QuantStudio Real-Time PCR equipment.

Thermo Fisher Scientific Inc.

 

ProClin Preservatives

 

ProClinTM preservatives are water-soluble biocide formulations among the most effective biocides in the IVD sector and are utilized in over 1,000 FDA-approved IVD kits from leading diagnostic companies.

Sigma-Aldrich Co. LLC.

 

KingFisher Apex System

 

The KingFisher Apex of Thermo Scientific is the pinnacle of automated DNA, RNA, protein, and cell purification.

Thermo Fisher Scientific Inc.

 

 

Frequently Asked Question About This Report

The global sterility testing market is expected to grow at a compound annual growth rate (CAGR) of 12.6% from 2021 to 2030 to reach USD 469.0 billion by 2030.

The global sterility testing market size was $161.18 Mn in 2021 and is predicted to reach $469.0 Mn by 2030, representing a CAGR of 12.6% during 2021 - 2030.

BioMerieux, Charles River Laboratories, Inc., Merck KGaA, Sartorius AG, SGS S.A., Sotera Health LLC, and Thermo Fisher Scientific, among others, are some of the markets key competitors.

Sterility testing is a GMP microbiological testing requirement that ensures the presence of sterile items before being released and administered to patients. Membrane filtration, Direct Transfer and Product Flush are the various types of sterility tests.

Fluid thioglycolate medium (FTM) is used for sterility testing.

Sterility testing usually requires two weeks of long incubation time as there exists some bacteria which are very slow in terms of growth, such as Propionibacterium acnes. P. acne is gram-positive, rod-shaped, slow-growing bacteria which is found in the acne of homosapians.

The global market is predicted to reach USD 469.0 million by 2030.


Sources

https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/the-next-wave-of-healthcare-innovation-the-evolution-of-ecosystems

https://economictimes.indiatimes.com/news/science/union-budget-2022-23-ministry-of-science-and-technology-allocated-rs-14217-crore/articleshow/89280245.cms?from=mdr

https://www.ibef.org/blogs/india-a-global-biotech-market

https://www.ibef.org/download/Medical-Devices-March-2021.pdf

https://ised-isde.canada.ca/site/industrial-technological-benefits/en

1.   Introduction

       1.1. Study Objective

       1.2. Market Definition        

       1.3. Study Scope

              1.3.1. Markets Covered

              1.3.2. Geographic Scope

              1.3.3. Years Considered

              1.3.4. Stakeholders

2.   Research Methodology

       2.1. Data Procurement

       2.2. Paid Database

              2.2.1. Secondary Data

                     2.2.1.1. Key Secondary sources

              2.2.2. Primary Data

                     2.2.2.1 Primary sources

                     2.2.2.2. Key industry insights

                     2.2.2.3. Primary interviews with experts

                     2.2.2.4. Key primary respondent list

       2.3. Market Size Estimation

       2.4. Bottom-Up and Top-Down Approaches

              2.4.1.     Bottom-Up Approach

                     2.4.1.1.         Approach for arriving at market size by bottom-up analysis

              2.4.2.     Top-Down Approach

                     2.4.2.1.         Approach for Capturing Market Size by Top-Down Analysis

       2.5. Market Breakdown and Data Triangulation

       2.6. Research Methodology

       2.7. Risk Assessment

3.  Executive Summary

       3.1  Sterility Testing Market: Post-Covid-19

              3.1.1      Actual Scenario

              3.1.2      Pessimistic Scenario

              3.1.3      Optimistic Scenario

              3.1.4      Market Summary

4. Industry Outlook

       4.1  Market Snapshot

       4.2  Regional  Analysis

              4.2.1      market, by region, 2021-2030 (USD Million)

       4.3  By Product  Analysis

              4.3.1      market, By Product, 2021-2030 (USD Million)

       4.4  By Test  Analysis

              4.4.1      market, By Test, 2021-2030 (USD Million)

       4.5  Application  Analysis

              4.5.1      market, By Application, 2021-2030 (USD Million)

       4.6  Value Chain Analysis

       4.7  Market Variable Analysis

              4.7.1      Market Drivers Analysis

              4.7.2      Market Restraints Analysis

       4.8  Environment Analysis Tool

              4.8.1      PEST analysis

              4.8.2      Porter’s analysis

       4.9 Penetration & Growth Prospect Mapping

5. Market Dynamics

       5.1. Introduction

       5.2. Market Dynamics

              5.2.1.     Drivers

              5.2.2.     Restraints

              5.2.3.     Opportunities

              5.2.4.     Challenges

       5.3. Impact of Covid-19 On Market

       5.4. Value Chain Analysis

       5.5. Ecosystem

       5.6. Patent Analysis

       5.7. Trade Analysis

       5.8. Tariff Analysis

       5.9. Case Study Analysis

5.10.      Porter’s Five Forces Analysis

              5.10.1    Threat of New Entrants

              5.10.2    Threat of Substitutes

              5.10.3    Bargaining Power of Buyers

              5.10.4    Bargaining Power of Suppliers

              5.10.5    Degree of Competition

       5.11.              Application Analysis

              5.11.1.   Trends in Application (2014-2020)

              5.11.2.   Trends in Application (2021-2028)

       5.12.              Pricing Analysis

              5.12.1.   Average Price Trend Analysis (By region, By Countries)

6. Competitive & Vendor Landscape

       6.1. Company Market Share Analysis

       6.2. Manufacturing Sites, Area Served, Product Product

       6.3. Market Competitive Situation and Trends

       6.4. Manufacturers Mergers & Acquisitions, Expansion Plans

7. Global Market: By Product Segment Analysis

       7.1. Introduction

       7.2. Sales Volume & Revenue Analysis (2021-2030)

       7.3. Kits and Reagents

              7.3.1. Kits and Reagents market, 2021-2030 (USD Million)

       7.4. Instruments

              7.4.1. Instruments market, 2021-2030 (USD Million)

       7.5. Services

              7.5.1. Services market, 2021-2030 (USD Million)

8. Global Market: By Test Segment Analysis

       8.1. Introduction

       8.2. Sales Volume & Revenue Analysis (2021-2030)

       8.3. Membrane Filtration

              8.3.1.     Membrane Filtration market, 2021-2030 (USD Million)

       8.4. Direct Inoculation

              8.4.1.     Direct Inoculation market, 2021-2030 (USD Million)

 

       8.5. Others

              8.5.1.     Others market, 2021-2030 (USD Million)

9. Global Market: By Application Segment Analysis

       9.1. Introduction

       9.2. Sales Volume & Revenue Analysis (2021-2030)

       9.3. Pharmaceutical and Biological Manufacturing

              9.3.1.     Pharmaceutical and Biological Manufacturing market, 2021-2030 (USD Million)

       9.4. Medical Devices Manufacturing

              9.4.1.     Medical Devices Manufacturing market, 2021-2030 (USD Million)

       9.5. Others Applications

              9.5.1.     Others Applications market, 2021-2030 (USD Million)

10. Global Market: Regional Outlook

       10.1 North America

              10.1.1.   North America  market, by By Product, 2021-2030 (USD Million)

              10.1.2.   North America  market, by By Test, 2021-2030 (USD Million)

              10.1.3.   North America  market, by Application, 2021-2030 (USD Million)

              10.1.4.   North America  market, by Country, 2021-2030 (USD Million)

       10.1.4.1. U.S.

                     10.1.4.1.1.   U.S. market, by By Product, 2021-2030 (USD Million)

                     10.1.4.1.2.   U.S. market, by By Test, 2021-2030 (USD Million)

                     10.1.4.1.3.   U.S. market, by Application, 2021-2030 (USD Million)

     10.1.4.2.  Canada

                     10.1.4.2.1.   Canada market, by By Product, 2021-2030 (USD Million)

                     10.1.4.2.2.   Canada market, by By Test, 2021-2030 (USD Million)

                     10.1.4.2.3.   Canada market, by Application, 2021-2030 (USD Million)

10.2. Europe

              10.2.1.   Europe market, by By Product, 2021-2030 (USD Million)

              10.2.2.   Europe market, by By Test, 2021-2030 (USD Million)

              10.2.3.   Europe market, by Application, 2021-2030 (USD Million)

              10.2.4.   Europe market, by country, 2021-2030 (USD Million)

    10.2.4.1    U.K.

                     10.2.4.1.1.   U.K. market, by By Product, 2021-2030 (USD Million)

                     10.2.4.1.2.   U.K. market, by By Test, 2021-2030 (USD Million)

                     10.2.4.1.3.   U.K. market, by Application, 2021-2030 (USD Million)

   10.2.4.2.           Germany

                     10.2.4.2.1.   Germany market, by By Product, 2021-2030 (USD Million)

                     10.2.4.2.2.   Germany market, by By Test, 2021-2030 (USD Million)

                     10.2.4.2.3.   Germany market, by Application, 2021-2030 (USD Million)

   10.2.4.3.           France

                     10.2.4.3.1.   France market, by By Product, 2021-2030 (USD Million)

                     10.2.4.3.2.   France market, by By Test, 2021-2030 (USD Million)

                     10.2.4.3.3.   France market, by Application, 2021-2030 (USD Million)

    10.2.4.4.          Rest of Europe

                     10.2.4.4.1.   Rest of Europe market, by By Product, 2021-2030 (USD Million)

                     10.2.4.4.2.   Rest of Europe market, by By Test, 2021-2030 (USD Million)

                     10.2.4.4.3.   Rest of Europe market, by Application, 2021-2030 (USD Million)

       10.3.              Asia Pacific

              10.3.1.   Asia Pacific market, by By Product, 2021-2030 (USD Million)

              10.3.2.   Asia Pacific market, by By Test, 2021-2030 (USD Million)

              10.3.3.   Asia Pacific market, by Application, 2021-2030 (USD Million)

              10.3.4.   Asia Pacific market, by country, 2021-2030 (USD Million)

   10.3.4.1.           China

                     10.3.4.1.1.   China market, by By Product, 2021-2030 (USD Million)

                     10.3.4.1.2.   China market, by By Test, 2021-2030 (USD Million)

                     10.3.4.1.3.   China market, by Application, 2021-2030 (USD Million)

   10.3.4.2.           India

                     10.3.4.2.1.   India market, by By Product, 2021-2030 (USD Million)

                     10.3.4.2.2.   India market, by By Test, 2021-2030 (USD Million)

                     10.3.4.2.3.   India market, by Application, 2021-2030 (USD Million)

   10.3.4.3.           Japan

                     10.3.4.3.1.   Japan market, by By Product, 2021-2030 (USD Million)

                     10.3.4.3.2.   Japan market, by By Test, 2021-2030 (USD Million)

                     10.3.4.3.3.   Japan market, by Application, 2021-2030 (USD Million)

   10.3.4.4.           South Korea

                     10.3.4.4.1.   South Korea market, by By Product, 2021-2030 (USD Million)

                     10.3.4.4.2.   South Korea market, by By Test, 2021-2030 (USD Million)

                     10.3.4.4.3.   South Korea market, by Application, 2021-2030 (USD Million)

10.3.4.5.              Rest of ASIA PACIFIC

                     10.3.4.5.1.   Rest of ASIA PACIFIC market, by By Product, 2021-2030 (USD Million)

                     10.3.4.5.2.   Rest of ASIA PACIFIC market, by By Test, 2021-2030 (USD Million)

                     10.3.4.5.3.   Rest of ASIA PACIFIC market, by Application, 2021-2030 (USD Million)

       10.4.              Latin America

              10.4.1.   Latin America market, by By Product, 2021-2030 (USD Million)

              10.4.2.   Latin America market, by By Test, 2021-2030 (USD Million)

              10.4.3.   Latin America market, by Application, 2021-2030 (USD Million)

              10.4.4.   Latin America market, by country, 2021-2030 (USD Million)

10.4.4.1.              Brazil

                     10.4.4.1.1.   Brazil market, by By Product, 2021-2030 (USD Million)

                     10.4.4.1.2.   Brazil market, by By Test, 2021-2030 (USD Million)

                     10.4.4.1.3.   Brazil market, by Application, 2021-2030 (USD Million)

10.4.4.2.              Mexico

                     10.4.4.2.1.   Mexico market, by By Product, 2021-2030 (USD Million)

                     10.4.4.2.2.   Mexico market, by By Test, 2021-2030 (USD Million)

                     10.4.4.2.3.   Mexico market, by Application, 2021-2030 (USD Million)

                     10.4.4.3.       Rest of the Latin America

                     10.4.4.3.1.   Rest of the Latin America market, by By Product, 2021-2030 (USD Million)

                     10.4.4.3.2.   Rest of the Latin America market, by By Test, 2021-2030 (USD Million)

                     10.4.4.3.3.   Rest of the Latin America market, by Application, 2021-2030 (USD Million)

       10.5.              MEA

              10.5.1.   MEA market, by By Product, 2021-2030 (USD Million)

              10.5.2.   MEA market, by By Test, 2021-2030 (USD Million)

              10.5.3.   MEA market, by Application, 2021-2030 (USD Million)

              10.5.4.   MEA market, by Region, 2021-2030 (USD Million)

 

11. Competitive Landscape

       11.1 Merck KGaA 

              11.1.1.   Company overview

              11.1.2.   Financial performance

              11.1.3.   Product Portfolio Analysis

              11.1.4.   Strategy & Recent Development

       11.2. BAXTER HEALTHCARE CORPORATION

              11.2.1.   Company overview

              11.2.2.   Financial performance

              11.2.3.   Product Portfolio Analysis

              11.2.4.   Strategy & Recent Development

       11.3. BOSTON ANALYTICAL

              11.3.1.   Company overview

              11.3.2.   Financial performance

              11.3.3.   Product Portfolio Analysis

              11.3.4.   Strategy & Recent Development

       11.4. NEOPHARM LABS INC.

              11.4.1.   Company overview

              11.4.2.   Financial performance

              11.4.3.   Product Portfolio Analysis

              11.4.4.   Strategy & Recent Development

       11.5. LEXAMED LTD

              11.5.1.   Company overview

              11.5.2.   Financial performance

              11.5.3.   Product Portfolio Analysis

              11.5.4.   Strategy & Recent Development

       11.6. Danaher Corporation

              11.6.1.   Company overview

              11.6.2.   Financial performance

              11.6.3.   Product Portfolio Analysis

              11.6.4.   Strategy & Recent Development

       11.7. Sartorius AG

              11.7.1.   Company overview

              11.7.2.   Financial performance

              11.7.3.   Product Portfolio Analysis

              11.7.4.   Strategy & Recent Development

       11.8. Gibraltar Laboratories

              11.8.1.   Company overview

              11.8.2.   Financial performance

              11.8.3.   Product Portfolio Analysis

              11.8.4.   Strategy & Recent Development

       11.9. Pace Analytical Services, Inc

              11.9.1.   Company overview

              11.9.2.   Financial performance

              11.9.3.   Product Portfolio Analysis

              11.9.4.   Strategy & Recent Development

       11.10. Sigma-Aldrich Co. LLC

              11.10.1. Company overview

              11.10.2. Financial performance

              11.10.3. Product Portfolio Analysis

              11.10.4. Strategy & Recent Development

       11.11. Nelson Laboratories

              11.11.1. Company overview

              11.11.2. Financial performance

              11.11.3. Product Portfolio Analysis

              11.11.4. Strategy & Recent Development

       11.12. Pacific Biolabs.

              11.12.1. Company overview

              11.12.2. Financial performance

              11.12.3. Product Portfolio Analysis

              11.12.4. Strategy & Recent Development

       11.13. BioConvergence LLC

              11.13.1. Company overview

              11.13.2. Financial performance

              11.13.3. Product Portfolio Analysis

              11.13.4. Strategy & Recent Development

       11.14. Thermo Fisher Scientific Inc

              11.14.1. Company overview

              11.14.2. Financial performance

              11.14.3. Product Portfolio Analysis

              11.14.4. Strategy & Recent Development

       11.15. Toxikon Corporation

              11.15.1. Company overview

              11.15.2. Financial performance

              11.15.3. Product Portfolio Analysis

              11.15.4. Strategy & Recent Development

       11.16. Wuxi Apptec

              11.16.1. Company overview

              11.16.2. Financial performance

              11.16.3. Product Portfolio Analysis

              11.16.4. Strategy & Recent Development

       11.17. Rapid Micro Biosystems, Inc.

              11.17.1. Company overview

              11.17.2. Financial performance

              11.17.3. Product Portfolio Analysis

              11.17.4. Strategy & Recent Development

 

 

List of Tables (63 Tables)

TABLE 1.  MARKET, By Product, 2021-2030 (USD Million)

TABLE 2.  MARKET FOR Kits and Reagents, BY REGION, 2021-2030 (USD Million)

TABLE 3.  MARKET FOR Instruments, BY REGION, 2021-2030 (USD Million)

TABLE 4.  MARKET FOR Services, BY REGION, 2021-2030 (USD Million)

TABLE 5. MARKET, By Test, 2021-2030 (USD Million)

TABLE 6. MARKET FOR Membrane Filtration, BY REGION, 2021-2030 (USD Million)

TABLE 7. MARKET FOR Direct Inoculation, BY REGION, 2021-2030 (USD Million)

TABLE 8. MARKET FOR Others Sterility Tests, BY REGION, 2021-2030 (USD Million)

TABLE 9. MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 10. MARKET FOR Pharmaceutical and Biological Manufacturing, BY REGION, 2021-2030 (USD Million)

TABLE 11. MARKET FOR Medical Devices Manufacturing, BY REGION, 2021-2030 (USD Million)

TABLE 12. MARKET FOR Others Applications, BY REGION, 2021-2030 (USD Million)

TABLE 13. MARKET, BY REGION, 2021-2030 (USD Million)

TABLE 14. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 15. NORTH AMERICA MARKET, By Product, 2021-2030 (USD Million)

TABLE 16. NORTH AMERICA MARKET, By Test, 2021-2030 (USD Million)

TABLE 17. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 18. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 19. EUROPE MARKET, By Product, 2021-2030 (USD Million)

TABLE 20. EUROPE MARKET, By Test, 2021-2030 (USD Million)

TABLE 21. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 22. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 23. ASIA-PACIFIC MARKET, By Product, 2021-2030 (USD Million)

TABLE 24. ASIA-PACIFIC MARKET, By Test, 2021-2030 (USD Million)

TABLE 25. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 26. LAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 27. LAMEA MARKET, By Product, 2021-2030 (USD Million)

TABLE 28. LAMEA MARKET, By Test, 2021-2030 (USD Million)

TABLE 29. LAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 30. Merck KGaA: COMPANY SNAPSHOT

TABLE 31. Merck KGaA: OPERATING SEGMENTS

TABLE 32. BAXTER HEALTHCARE CORPORATION: COMPANY SNAPSHOT

TABLE 33. BAXTER HEALTHCARE CORPORATION: OPERATING SEGMENTS

TABLE 34. BOSTON ANALYTICAL: COMPANY SNAPSHOT

TABLE 35. BOSTON ANALYTICAL: OPERATING SEGMENTS

TABLE 36. NEOPHARM LABS INC. : COMPANY SNAPSHOT

TABLE 37. NEOPHARM LABS INC. : OPERATING SEGMENTS

TABLE 38. LEXAMED LTD: COMPANY SNAPSHOT

TABLE 39. LEXAMED LTD: OPERATING SEGMENTS

TABLE 40. Danaher Corporation: COMPANY SNAPSHOT

TABLE 41. Danaher Corporation: OPERATING SEGMENTS

TABLE 42. Sartorius AG: COMPANY SNAPSHOT

TABLE 43. Sartorius AG: OPERATING SEGMENTS

TABLE 44. Gibraltar Laboratories: COMPANY SNAPSHOT

TABLE 45. Gibraltar Laboratories: OPERATING SEGMENTS

TABLE 46. Pace Analytical Services, Inc: COMPANY SNAPSHOT

TABLE 47. Pace Analytical Services, Inc: OPERATING SEGMENTS

TABLE 48. Sigma-Aldrich Co. LLC: COMPANY SNAPSHOT

TABLE 49. Sigma-Aldrich Co. LLC: OPERATING SEGMENTS

TABLE 50. Nelson Laboratories: COMPANY SNAPSHOT

TABLE 51. Nelson Laboratories: OPERATING SEGMENTS

TABLE 52. Pacific Biolabs: COMPANY SNAPSHOT

TABLE 53. Pacific Biolabs: OPERATING SEGMENTS

TABLE 54. BioConvergence LLC: COMPANY SNAPSHOT

TABLE 55. BioConvergence LLC: OPERATING SEGMENTS

TABLE 56. Thermo Fisher Scientific Inc: COMPANY SNAPSHOT

TABLE 57. Thermo Fisher Scientific Inc: OPERATING SEGMENTS

TABLE 58. Toxikon Corporation: COMPANY SNAPSHOT

TABLE 59. Toxikon Corporation: OPERATING SEGMENTS

TABLE 60. Wuxi Apptec: COMPANY SNAPSHOT

TABLE 61. Wuxi Apptec: OPERATING SEGMENTS

TABLE 62. Rapid Micro Biosystems, Inc.: COMPANY SNAPSHOT

TABLE 63. Rapid Micro Biosystems, Inc.: OPERATING SEGMENTS

 

 

List of Figures (22 Figures)

Figure 1 Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries

Figure 4 Research Methodology: Hypothesis Building

Figure 5 Product-Based Estimation

Figure 6 Top 17 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2020

Figure 8 Import Data for Sterility Testing, By Country, 2016–2020 (USD Thousand)

Figure 9 Export Data for Sterility Testing, By Country, 2016–2020 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11 Market, By Test, 2019 vs. 2025 (USD Million)

Figure 12 Market Share, By Application, 2019 vs. 2025 (USD Million)

Figure 13 Market Share, By Product, 2019 vs. 2025 (USD Million)

Figure 14 Geographical Snapshot of the Market

Figure 15 Kits and Reagents to Witness Higher CAGR in Market for Product Segment during Forecast Period.

Figure 16 Pharmaceutical and Biological Manufacturing to Witness Higher CAGR in Market for Application Segment during Forecast Period.

Figure 17 Membrane Filtration to Witness Higher CAGR in Market for Test Segment during Forecast Period.

Figure 18 North American region Accounted for the Largest Share of the Market, By Regional Basis, in 2019

Figure 19 Drivers, Restraints, Opportunities, and Challenges

Figure 20 North America: Market Snapshot

Figure 21 Asia Pacific: Market Snapshot

Figure 22 Vendor Dive: Evaluation Overview

Choose License Type


$4485
$6449
$8339
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization
Related Reports
Buy Now
Request Sample

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: +1-315-636-4233
  • UK: +44-162-237-0614
  • IN: +91-826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved.